Universal Health Services Inc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Universal Health Services Inc (UHS). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Acute Care Hospital Services | $6.34B 54.5% | $7.11B 55.9% · +12.2% | $7.65B 56.8% · +7.6% | $8.08B 56.3% · +5.7% | $8.94B 56.3% · +10.7% | $9.93B 57.0% · +11.0% |
| Behavioral Health Services | $5.21B 44.8% | $5.50B 43.3% · +5.7% | $5.73B 42.5% · +4.1% | $6.19B 43.1% · +8.0% | $6.87B 43.3% · +11.0% | $7.43B 42.6% · +8.0% |
| State Medicaid programs | $73.0M 0.6% | $74.0M 0.6% · +1.4% | $75.0M 0.6% · +1.4% | $73.0M 0.5% · -2.7% | $53.0M 0.3% · -27.4% | $56.0M 0.3% · +5.7% |
| Other | $12.9M 0.1% | $30.2M 0.2% · +134.8% | $22.9M 0.2% · -24.3% | $9.7M 0.1% · -57.8% | $10.6M 0.1% · +9.4% | $13.4M 0.1% · +27.1% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by product line
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Managed Care (HMO and PPOs) | $3.43B 29.6% | $3.96B 31.3% · +15.5% | $4.01B 29.9% · +1.4% | $4.21B 29.5% · +4.9% | $4.50B 28.4% · +6.8% | $4.90B 28.2% · +9.0% |
| Medicaid | $1.20B 10.4% | $1.29B 10.2% · +7.4% | $1.51B 11.3% · +17.1% | $1.53B 10.7% · +1.4% | $2.25B 14.2% · +46.9% | $2.69B 15.5% · +19.3% |
| Managed Medicaid | $1.72B 14.8% | $1.95B 15.4% · +13.5% | $2.21B 16.5% · +13.3% | $2.29B 16.0% · +3.8% | $2.30B 14.6% · +0.6% | $2.48B 14.3% · +7.8% |
| Managed Medicare | $1.10B 9.6% | $1.36B 10.8% · +23.4% | $1.56B 11.6% · +14.5% | $1.71B 12.0% · +9.8% | $1.88B 11.9% · +9.9% | $2.08B 12.0% · +10.4% |
| Medicare | $1.69B 14.6% | $1.65B 13.1% · -2.2% | $1.62B 12.1% · -2.3% | $1.61B 11.3% · -0.5% | $1.67B 10.5% · +3.8% | $1.86B 10.7% · +11.2% |
| Other Patient Revenue and Adjustments, Net | $745.3M 6.4% | $843.2M 6.7% · +13.1% | $745.6M 5.6% · -11.6% | $981.2M 6.9% · +31.6% | $1.11B 7.0% · +13.4% | $1.24B 7.1% · +11.5% |
| Other Non-patient Revenue | $1.09B 9.4% | $898.1M 7.1% · -17.5% | $1.06B 7.9% · +18.1% | $1.18B 8.3% · +11.6% | $1.23B 7.8% · +3.9% | $1.11B 6.4% · -9.3% |
| UK Revenue | $584.0M 5.1% | $687.7M 5.4% · +17.8% | $684.6M 5.1% · -0.5% | $761.1M 5.3% · +11.2% | $880.1M 5.6% · +15.6% | $1.00B 5.8% · +13.8% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.